Drug intelligence / Profile preview

rongxue bunao ye

Development stage: Unknown
Lead developer: Liaoning Jindan Pharmaceutical
Administration: Oral

Overview

Rongxue Bunao Ye is a traditional Chinese medicine (TCM) oral solution developed and manufactured by Liaoning Jindan Pharmaceutical. The primary active component is deer blood (Cervus nippon or Cervus elaphus), which is traditionally utilized in TCM to tonify the kidneys, replenish essence, and nourish the blood. It is specifically indicated for the treatment of neurasthenia, dizziness, insomnia, forgetfulness, and physical fatigue resulting from qi and blood deficiency. The product is marketed as an over-the-counter (OTC) medication in China, intended to improve cognitive symptoms and overall vitality through the synergistic effects of biological constituents found in deer blood, such as amino acids, polypeptides, and trace elements.

Brand names: 茸血补脑液Rongxue Bunao Ye
Other names: Rongxue Bunao Oral Solution

Beyond the preview

Go deeper on rongxue bunao ye.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on rongxue bunao ye.

Explore the full profile